Cargill's animal nutrition business announced that it has expanded its voluntary recall of select Southern States feed due to aflatoxin levels that exceed the Food & Drug Administration's action levels.

Cargill explained that this is an expansion of the May 6 recall and is the result of its internal investigation that identified additional products containing an ingredient provided from the same supplier referenced in the May 6 recall announcement.

The expanded recall includes products manufactured between Oct. 31, 2018, and March 1, 2019.

Livestock, horses and poultry exposed to elevated levels of aflatoxin are at risk of exposure to several health effects, Cargill said. Aflatoxicosis has the same acute and chronic adverse effects and health consequences across all species and age classes (immature and mature). Immature animals are more sensitive to aflatoxins. Acute aflatoxicosis may result in generalized hemorrhage, bloody diarrhea and death in one to three days. In addition, aflatoxin toxicity can cause reduced feed intake, reduced weight gain, liver damage, jaundice and eventually death.

Cargill said it has received a small number of adverse event reports, which are being investigated to determine if they are related to the recalled feed. Cargill is voluntarily expanding the scope of this recall.

Related:Cargill recalls some feed due to aflatoxin

The affected products were manufactured at Cargill's Cleveland, N.C., facility and are being recalled from retail outlets and distributors in these markets: Alabama, Connecticut, Delaware, Florida, Georgia, Indiana, Kentucky, Maine, Maryland, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Vermont, Virginia and West Virginia.

The complete list of affected products is available from Cargill.

Consumers and other end users who have any of the affected lots in their possession should return remaining product to their local dealer or retailer for a replacement or full refund. For more information, call 833-224-2003.

Cargill said the recall is being conducted with the knowledge of and in cooperation with FDA.